Hot Investor Mandate 4: Asia-based Pharma Seeks Repurposed Drugs

10 Mar

The in-licensing arm of an Asia-based pharma company with several US offices is seeking partnerships with companies based in the USA.

The firm seeks specialty biotech therapeutics in neurobiology, dermatology, respiratory, oncology and ophthalmology indications. The firm focuses on technology that are 2-3 years from the market and with a 505(b) (2) regulatory pathway. The firm will consider in-licensing and acquisitions in these specialty areas.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: